New York: Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants has fallen ill.
The 60,000-patient clinical trial met the criteria for a “pausing rule”, reported Stat News, reporting that the online system that enrols patients has been closed and the independent committee that monitors patient safety in the clinical trial will be convened.
Johnson & Johnson confirmed it has temporarily paused the trial.
The participant’s illness was being reviewed and evaluated by an independent data and safety monitoring board as well as its clinical and safety physicians, the company said. Read more…..
Chart of the Day
Johnson & Johnson has begun its phase three trial testing its potential coronavirus vaccine, the pharmaceutical company announced Wednesday.